Breaking News, Promotions & Moves

Dynavax Names CEO

Gray brings 30 years of industry experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eddie Gray has been appointed chief executive officer and a member of the board at Dynavax Technologies Corp. Mr. Gray succeeds Dino Dina, M.D., who will remain a consultant to the company for a transition period and plans to continue serving as a board member. Also, president Tyler Martin, M.D., is leaving the company on May 31, 2013 and plans to remain a consultant for a transition period.   Most recently, Mr. Gray served as the president of Pharmaceuticals Europe at GlaxoSmithKline since 2008...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters